1)thromboembolic diseasesѪ˨˨ÈûÖ¢
1.Objective To investigate the role of prothrombin variant 20210 G to A in Chinese patients with thromboembolic diseases.Ä¿µÄ¡¡Ñо¿ÄýѪøԻùÒò£Ç£²£°£²£±£°£Á±äÒìÔÚѪ˨˨ÈûÖ¢µÄ·¢²¡Çé¿ö¡£
Ó¢ÎĶ̾ä/Àý¾ä
1.The Study of Embolism Factors in Pulmonary Thromboembolism;·ÎѪ˨˨ÈûÖ¢»¼ÕßѪ˨ÐÔÒòËØµÄÑо¿
2.48 Cases on the Diagnosis and Analysis of Treatment of PTE;·ÎѪ˨˨ÈûÖ¢48ÀýÕï¶ÏÓëÖÎÁÆ·ÖÎö
3.A Systematic Review of Diagnostic Tests for Pulmonary Embolism;·ÎѪ˨˨ÈûÖ¢Õï¶ÏÐÔÊÔÑéµÄϵͳÆÀ¼Û
4.Comparative Clinical Analysis of 163 Pulmonary Thromboembolism Patients;·ÎѪ˨˨ÈûÖ¢163ÀýÁÙ´²¶Ô±È·ÖÎö
5.The Role of Wells Rule in Patients with Pulmonary ThromboembolismWellsÆÀ·ÖÔÚ·ÎѪ˨˨ÈûÖ¢Õï¶ÏÖеļÛÖµ
6.Clinical Analysis of 78 Cases of Acute Pulmonary Thromboembolism78Àý¼±ÐԷζ¯ÂöѪ˨˨ÈûÖ¢ÁÙ´²·ÖÎö
7.Study on the Serologic Markers of Early Stage of Pulmonary Thromboembolism;·ÎѪ˨˨ÈûÖ¢ÔçÆÚѪÇåѧ±êÖ¾ÎïµÄÑо¿
8.Pulmonary Thromboembolism and the Disturbances of Coagulation and Fibrinolysis;·Î¶¯ÂöѪ˨˨ÈûÖ¢ÓëÄýѪÏËÈÜϵͳʧºâ
9.The Correlation Analysis of Venous Thromboembolism with the Levels and Polymorphisms of Coagulation Factor ¢øÄýѪÒò×Ó¢øÓë¾²ÂöѪ˨˨ÈûÖ¢Ïà¹ØÐÔÑо¿
10.Diagnostic value of arterial blood gas analysis in acute pulmonary thromboembolismÑªÆø·ÖÎö¶Ô¼±ÐÔ·ÎѪ˨˨ÈûÖ¢Õï¶ÏµÄ¼ÛÖµ
11.The correlation analysis of embolism area and basis diseases in patients with pulmonary thromboembolism129ÀýסԺ·ÎѪ˨˨ÈûÖ¢»¼Õß˨ÈûÃæ»ýÓë»ù´¡¼²²¡Ïà¹ØÐԵķÖÎö
12.Probing into the Risk Profile of Pulmonary Thromboembolism in Chinese Population;ÖйúÈËȺ·Î¶¯ÂöѪ˨˨ÈûÖ¢Ò׸ÐÒòËØÑо¿
13.The Comparison of Clinical Characteristics for Pulmonary Thromboembolism in Elder Patients and Younger Patients;ÀÏÄêÈËÓëÖÐÇàÄê·ÎѪ˨˨ÈûÖ¢ÁÙ´²ÌصãµÄ±È½Ï
14.The Clinical Study of IL-1¦Â¡¢TNF-¦Á¡¢IL-8 in Acute Pulmonary Thromboembolism;¼±ÐÔ·ÎѪ˨˨ÈûÖ¢IL-1¦Â¡¢TNF-¦Á¡¢IL-8µÄÁÙ´²Ñо¿
15.Dual source CT for venous thromboembolism before interventional therapy¾²ÂöѪ˨˨ÈûÖ¢½éÈëÕïÁÆÊõǰµÄ˫ԴCT¼ì²é
16.Venous thromboembolism in non-small-cell lung cancer patients:Report of 15 cases·Î°©ºÏ²¢¾²ÂöѪ˨˨ÈûÖ¢15ÀýÁÙ´²·ÖÎö
17.Research on Electrocardiogram of Acute Pulmonary Thromboembolism¼±ÐÔ·ÎѪ˨˨ÈûÖ¢ÁÙ´²Ðĵçͼ·ÖÎöÑо¿
18.Diagnostic Value of Echocardiography in Acute Pulmonary Thromboembolism³¬ÉùÐĶ¯Í¼¶Ô¼±ÐÔ·ÎѪ˨˨ÈûÖ¢Õï¶ÏµÄ¼ÛÖµ
Ïà¹Ø¶Ì¾ä/Àý¾ä
venous thromboembolism¾²ÂöѪ˨˨ÈûÖ¢
1.Polymorphisms of tissue factor pathway inhibitors C-399T in venous thromboembolism¾²ÂöѪ˨˨ÈûÖ¢×éÖ¯Òò×Ó;¾¶ÒÖÖÆÎïC-399T¶à̬ÐÔµÄÑо¿
2.Besides pre-test clinical evaluation and D-dimer assay,there are many of diagnostic modalities,including CT pulmonary angiography which gradually be as the first choice,to be used in diagnosing of venous thromboembolism.¾²ÂöѪ˨˨ÈûÖ¢°üº¬Éî¾²ÂöѪ˨ÐγɺͷÎѪ˨˨ÈûÖ¢,ÊǾßÓжàÖÖΣÏÕÒòËØµÄDZÔÚÖÂËÀÐÔ¼²²¡,ÆäÁ÷Ðв¡Ñ§×ÊÁÏÑо¿ÏÔʾ²¢·ÇÉÙ¼û¼²²¡¡£
3.Deep vein thrombosis(DVT) and pulmonary thromboembolism(PTE) are separate but related aspects of the same dynamic disease process know as venous thromboembolism(VTE).¾²ÂöѪ˨˨ÈûÖ¢(venous thromboembolism,VTE)°üÀ¨·ÎѪ˨˨ÈûÖ¢(pulmonary thromboembolism,PTE)ºÍÉî¾²ÂöѪ˨ÐγÉ(deep venous thrombosis, DVT)¡£
3)Pulmonary thromboembolism·ÎѪ˨˨ÈûÖ¢
1.Effect of L-arginine on expressions of eNOS and COX2 in pulmonary thromboembolism;L-¾«°±Ëá¶Ô·ÎѪ˨˨ÈûÖ¢eNOSºÍCOX2±í´ïµÄÓ°Ïì
2.Prognostic value of elevated cardiac troponin T levels in acute pulmonary thromboembolism;¼¡¸Æµ°°×T¶Ô¼±ÐÔ·ÎѪ˨˨ÈûÖ¢»¼ÕßÔ¤ºóÆÀ¹À¼ÛÖµ
3.The effect of anticoagulant and thrombolytic therapy on arterial blood gas with acute pulmonary thromboembolism;¿¹ÄýÓëÈÜ˨ÖÎÁƶԼ±ÐÔ·ÎѪ˨˨ÈûÖ¢»¼ÕßÑªÆøµÄÓ°Ïì
4)pulmonary thromboembolism(PTE)·ÎѪ˨˨ÈûÖ¢
1.Objective To evaluate the curative effect of interventional comprehensive therapy for pulmonary thromboembolism(PTE).Ä¿µÄÆÀ¼Û½éÈë×ÛºÏÖÎÁƼ±ÐÔ·ÎѪ˨˨ÈûÖ¢(PTE)µÄÁÆÐ§¡£
2.Objective: To diagnose the pulmonary thromboembolism(PTE) by using the radionuclide imaging scan and other clinical techniques.Ä¿µÄ:ÀûÓ÷κËËØÓ°ÏñɨÃè¼ì²é¼°·Î¶¯ÂöÔìÓ°µÈÆäËüÁÙ´²ÊÖ¶Î,¶Ô·ÎѪ˨˨ÈûÖ¢(PTE)½øÐÐÃ÷È·Õï¶Ï;´ÓÁÙ´²»ù´¡Ì½ÌÖPTEÖ²¡µÄΣÏÕÒòËØ¡£
5)Thromboembolism[Ó¢][,¦Èr?mb?u'emb?liz?m][ÃÀ][,¦Èr¨»mbo'?mb?,l?zm?]Ѫ˨˨Èû
1.A Control Study of Thromboembolism Events betwween Systemic Lupus Erythematosus and Other Rheumatic Disease;ϵͳÐÔºì°ßÀÇ´¯ÓëÆäËû·çʪ²¡µÄѪ˨˨ÈûÐÔ¼²²¡¶Ô±ÈÑо¿
2.The relationship between the characteristics of fibrillory wave and thromboembolism events in patients with chronic nonvalvular atrial fibrillation;³ÖÐøÐԷǰêĤÐÄ·¿²ü¶¯»¼ÕßÐĵçͼf²¨ÌصãÓëѪ˨˨ÈûʼþµÄ¹ØÏµ
3.Effect of Aspirin on Thromboembolism in Hypertensive Patients Associated with Paroxysmal Atrial Fibrillation;°¢Ë¾Æ¥ÁÖ¶ÔÔ·¢ÐÔ¸ßѪѹ°éÕó·¢ÐÔÐÄ·¿²ü¶¯ÑªË¨Ë¨ÈûµÄÔ¤·À×÷ÓÃ
6)thrombo-embolismѪ˨˨Èû
1.Comparative study of the effect of warfarin with aspirin on preventing atrial fibrillation from thrombo-embolism;»ª·¨ÁîºÍ°¢Ë¹Æ¥ÁÖÔ¤·ÀÐÄ·¿²ü¶¯²¢·¢ÑªË¨Ë¨ÈûµÄ±È½ÏÑо¿
2.Clinical Observation of Different Anticoagulate Intensity of Warfarin in Prevention of Thrombo-embolism on 212 Patients with Nonrheumatic;²»Í¬¿¹ÄýÇ¿¶È»ª·¨ÁîÔ¤·À·Ç°êĤ²¡ÐÄ·¿²ü¶¯»¼ÕßѪ˨˨Èû(¸½212ÀýÁÙ´²¹Û²ì)
3.Objective:To investigate the efficacy and safety of Warfarin different anticoagulation intensities and aspirin preventing thrombo-embolism in nonvalvular atrial fibrillation.5)ºÍ°¢Ë¾Æ¥ÁÖ×é,¹Û²ìÈý×éѪ˨˨Èû²¢·¢Ö¢ºÍ³öѪµÈ²»Á¼·´Ó¦µÄ·¢ÉúÂÊÒÔ¼°C-·´Ó¦µ°°×Ũ¶È±ä»¯¡£
ÑÓÉìÔĶÁ
Ѫ˨˨ÈûѪ˨˨Èû¡¡¡¡ÑªË¨Ë¨×ÓÒýÆðµÄ˨Èû¡£ÓÉÓÚѪ˨˨×ÓµÄÀ´Ô´²»Í¬£¬Æä˨ÈûµÄ²¿Î»Ò²²»Í¬¡£ÈçÏÂÖ«¾²ÂöÐγɵÄѪ˨˨×Ó¶àͨ¹ýÓÒÐÄ¡¢ÒýÆð·Î¶¯Âö˨Èû£»×óÐÄ·¿¡¢×óÐÄÊÒ¡¢¶¯ÂöѪ¹Ü»òÖ÷¶¯ÂöÁöÄÚµÄѪ˨˨×Ó£¬¿É˨ÈûÔÚÈÎºÎÆ÷¹ÙºÍ×éÖ¯µÄ¶¯Âö·ÖÖ§´¦£¬ÆäÖУ¬ÐÄ¡¢ÄÔ¡¢Éö¡¢Æ¢½ÏΪ¶à¼û¡£ÕâЩѪ˨˨×ÓÓÖÒò˨×ӵĴóС¡¢Ë¨ÈûµÄ²¿Î»ºÍ²à֦ѻ·½¨Á¢µÈµÄ²»Í¬£¬¶Ô»úÌåµÄÓ°ÏìÒ²²»Í¬¡£Ð¡µÄѪ˨˨×Ó˨ÈûϸСѪ¹Ü£¬Ó°Ïì½ÏС£¬Èç¹û½Ï´óµÄѪ˨˨×Ó˨ÈûÐÄ¡¢ÄÔ³£¿É·¢Éú¹£ËÀ£¬ÑÏÖØÕß¿ÉΣ»úÉúÃü¡£¡¡¡¡
